Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Facebook
LinkedIn
Fill out the form below to download this content.
Leveraging-a-Humanized-SLE-Mouse-Model-to-Evaluate-Next-Generation-Immune-Cell-Targeted-Therapeutics

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics

Name(Required)
By clicking submit you consent to receive email communications about products and services of Medicilon and are in accordance with our Privacy Policy. You may opt out at any time.

Search Medicilon

Preclinical CRO

Medicilon TPD (PROTAC, Molecular Glue) Service Platform

Preclinical CRO

Medicilon’s Antibody-Peptide Conjugates Service Platform

Preclinical CRO

ACEA Pharma’s Ogrelvir Sodium Capsule Named in Nature’s 2025 Top Novel Target Drugs List with R&D Support from Medicilon

Contact Medicilon

Name(Required)
Address(Required)